Drug Profile
L-NIL
Alternative Names: N-iminoethyl-L-lysineLatest Information Update: 02 Aug 2002
Price :
$50
*
At a glance
- Originator Pharmacia Corporation
- Class Antirheumatics
- Mechanism of Action Nitric oxide synthase type II inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Inflammation; Osteoarthritis; Rheumatoid arthritis